DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $245,122 | +3.4% | 988 | 0.0% | 0.04% | +11.1% |
Q2 2023 | $237,120 | -7.5% | 988 | -2.9% | 0.04% | -10.0% |
Q1 2023 | $256,324 | -5.0% | 1,017 | 0.0% | 0.04% | -11.1% |
Q4 2022 | $269,932 | -99.9% | 1,017 | 0.0% | 0.04% | -6.2% |
Q3 2022 | $262,680,000 | +1.9% | 1,017 | 0.0% | 0.05% | +9.1% |
Q2 2022 | $257,829,000 | +18.5% | 1,017 | +37.1% | 0.04% | +29.4% |
Q1 2022 | $217,651,000 | -10.8% | 742 | 0.0% | 0.03% | -5.6% |
Q4 2021 | $244,125,000 | -3.9% | 742 | -11.0% | 0.04% | -12.2% |
Q3 2021 | $253,902,000 | +17.8% | 834 | +3.9% | 0.04% | +13.9% |
Q2 2021 | $215,493,000 | +32.4% | 803 | +11.1% | 0.04% | +12.5% |
Q1 2021 | $162,732,000 | +1.3% | 723 | 0.0% | 0.03% | -5.9% |
Q4 2020 | $160,607,000 | -23.2% | 723 | -25.5% | 0.03% | -32.0% |
Q3 2020 | $209,085,000 | +25.5% | 971 | +3.1% | 0.05% | +28.2% |
Q2 2020 | $166,574,000 | +20.0% | 942 | -6.1% | 0.04% | -4.9% |
Q1 2020 | $138,825,000 | -9.8% | 1,003 | 0.0% | 0.04% | +7.9% |
Q4 2019 | $153,940,000 | +10.5% | 1,003 | +3.9% | 0.04% | -9.5% |
Q3 2019 | $139,374,000 | +1.1% | 965 | 0.0% | 0.04% | -6.7% |
Q2 2019 | $137,917,000 | +8.3% | 965 | 0.0% | 0.04% | -2.2% |
Q1 2019 | $127,399,000 | +20.8% | 965 | -5.7% | 0.05% | +9.5% |
Q4 2018 | $105,491,000 | +0.7% | 1,023 | +6.0% | 0.04% | +20.0% |
Q3 2018 | $104,731,000 | -63.6% | 965 | -66.6% | 0.04% | -65.7% |
Q2 2018 | $287,985,000 | +204.8% | 2,892 | +199.7% | 0.10% | +251.7% |
Q1 2018 | $94,483,000 | – | 965 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |